Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Global Uterine Cancer Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. This report,…
DUBLIN–(BUSINESS WIRE)–The “Global Uterine Cancer Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. This report,…
DUBLIN–(BUSINESS WIRE)–The “Global Osteoporosis Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Osteoporosis Pipeline Highlights…
CHICAGO & MARCY L’ÉTOILE, France–(BUSINESS WIRE)–For this inaugural World Food Safety Day, Mérieux NutriSciences and bioMérieux conducted an international consumer…
Deal will accelerate drug development for Duchenne muscular dystrophy, a rare disease that affects 300,000 boys and young men worldwide…
Cedazuridine and decitabine, administered orally as a fixed-dose combination (ASTX727), met the primary endpoint of decitabine exposure equivalence of total…
-Provides Vertex with leading gene editing capabilities to develop novel therapies for Duchenne Muscular Dystrophy and Myotonic Dystrophy Type 1-…
— Hans Bishop, GRAIL Board Member and Former CEO of Juno Therapeutics, Will Succeed Jennifer Cook — — Joshua Ofman…
CULVER CITY, Calif.–(BUSINESS WIRE)–NantKwest (Nasdaq:NK) today announced the appointment of Cheryl L. Cohen to the Board of Directors of NantKwest,…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem…